The preliminary result has demonstrated an improving trend of patient survival in the metformin group, although it failed to reach statistical significance.
← all excerpts
Prognostic impact of metformin in solid cancer patients receiving immune checkpoint inhibitors: novel evidences from a multicenter retrospective study.
1
—
—